Attending #ESCRS2024 ? Stop by our booth where we will showcase our innovative digital solution for patients experiencing post-surgery complications. RevitalVision's cortical stimulation technology is a clinically proven solution designed to improve vision after #cataract and #refractivesurgery, as well as in various eye conditions, including stable #keratoconus, #amblyopia, and more. Patients who may benefit from RevitalVision include: ❇ Multifocal, EDOF and Mono Vision patients, struggling with neuro-adaptation ❇Post RLE patients complaining on vision quality ❇Patients with low contrast sensitivity and poor night vision ❇Keratoconus patients post crosslinking, intrastromal implants, or keratoplasty ❇Adults with Amblyopia ❇ Patients with a minor refractive error, needing to improve uncorrected vision We look forward to meeting you at our #booth G58 to explore how #RevitalVision can make a significant impact on your practice by optimizing visual outcomes, increasing patient satisfaction, and growing your clinic's revenue. See you there! #ESCRS2024 #revitalvision #ophthalmologists #eyecareprofessionals The European Society of Cataract and Refractive Surgeons (ESCRS)
RevitalVision
Medical Equipment Manufacturing
modiin, Israel 1,444 followers
From Brain Science to Full Vision
About us
RevitalVision is a SaaS-based, digital health startup offering a unique solution to 500 million people whose needs are unmet by existing vision treatments. Our non-invasive technology enhances eyesight neurologically. Its thousands of clinical trial participants and commercial customers have reported and tested with significant improvement in their vision performance by 2.5 lines on the visual acuity eye chart, and a 100% increase in contrast sensitivity on average for all product categories. We offer eye care specialists a simple, easy-to-use tool to improve patient's vision beyond current eye treatments, and an additional revenue channel. We also offer eye surgery clinics a unique tool to reduce non-paid post-surgery visits of cataract and refractive patients. RevitalVision is the only FDA-cleared product for children older than 9 and adults with amblyopia a leading cause for impaired vision affecting 3-5% of the world population. Brain science and proprietary algorithm-based technology, clinically validated in multiple eye diseases and vision impairments, and has been approved for two new USA CPT codes by the American Medical Association for the treatment of amblyopia. RevitalVision is also CE-Marked with a broad indication for use, for vision improvement above age 9.
- Website
-
http://www.revitalvision.com
External link for RevitalVision
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- modiin, Israel
- Type
- Privately Held
- Founded
- 2019
- Specialties
- startup, vision care, eye care, SaaS, and Digital Therapeutics
Locations
-
Primary
Hama'ayan
2
modiin, Israel 7177871, IL
Employees at RevitalVision
Updates
-
🌟 RevitalVision Wins the VSP Vision & MATTER Innovation Challenge! 🌟 We are thrilled and honored to be selected as the winner of the VSP Vision & MATTER Innovation Challenge! The VSP Vision & MATTER Innovation Challenge is a prestigious competition designed to identify and support groundbreaking technologies that have the potential to advance vision care. This award validates the value of our technology, and we are looking forward to the adoption of our life changing vision care solution by the industry. Thank you VSP Vision and MATTER, for this remarkable recognition and opportunity. We are inspired by the innovative solutions we encountered throughout this challenge and look forward to collaborating with this talented community in the future. Eye care professionals: Join us on our journey to redefine vision care. Working together, imagine the positive difference we can make on the lives of patients everywhere. https://lnkd.in/dpPvXz3Y #InnovationChallenge #VisionHealth #RevitalVision #eyecare #Eyecareprofessionals #HealthcareInnovation #digitalhealth
-
-
Join us on August 15 for the #VSPVisionInnovationChallenge! We are extremely excited and honored to be one of the five finalists participating and presenting our groundbreaking technology to industry leaders at this event. RSVP here: https://lnkd.in/e2VPH-RK #healthcare #entrepreneurs #innovation #eycareprofessionals #digitalhealth #VSPVisionInnovationChallenge MATTER VSP Global Innovation Center Yair Yahav Charles Morris
📣 Would you like to be in the room when the VSP Global Innovation Center and MATTER announce the winner of the #VSPVisionInnovationChallenge? On August 15, join us, #healthcare innovators, industry professionals, #entrepreneurs, investors, and more in-person at MATTER or virtually to hear pitches from the five Challenge finalists. Additionally, hear from our keynote speakers, Visibly CEO Brent Rasmussen and Head of the VSP Global Innovation Center Ruth Yomtoubian. The finalists—Lens2Recycle, machineMD, Ophthalytics Inc, RevitalVision and Vision Science Labs—will present to a panel of industry leaders for a chance to win $10,000 for first, $5,000 for second, and $5,000 for an audience choice award. Click on this link to RSVP: https://lnkd.in/e2VPH-RK #visioninnovation #visioncare #eyecare #VSPVision #innovation
-
-
We are excited to announce that we are one of the five finalists globally selected to participate in the VSP Vision Innovation Challenge! The VSP Vision Innovation Challenge, hosted by MATTER, is a prestigious competition designed to identify and support cutting-edge startups and innovators in the vision care industry. This challenge aims to discover solutions that can significantly enhance eye care delivery and improve the overall patient experience. As part of this challenge, we will have the opportunity to collaborate with industry leaders and showcase our groundbreaking vision improvement solution to a global audience. Thank you VSP Vision and MATTER for this incredible opportuinity. Visit the MATTER blog to learn more about the finalists and the showcase taking place on August 15 ➡️ https://bit.ly/4eWw3f7 Stay tuned for more exciting developments! #eyecare #ophthalmology #visioncare #medicaldevices #VisionInnovation #eyecareprofessionals
-
-
Thank you ISRAEL21C for this enlightening article about #RevitalVision home based vision training program. The article beautifully illustrates how our simple home-based brain training technology greatly enhances vision and quality of life for our patients Read the full article https://lnkd.in/d3BjwK3s ##braintraining #innovativetechnology ##medicaldevice #digitalhealth #visionimprovement
-
We are thrilled to announce that Prof. Yair Morad will be presenting RevitalVision at the ESA-ISA 2024 Joint Meeting of the European and International Strabismological Associations, taking place in Toulouse France 13-15 June. This event brings together the leading minds in pediatric ophthalmology, strabismus, orthoptic, and binocular vision, to share knowledge, exchange ideas, and explore the latest developments in these areas. Professor Yair Morad will speak about Adult Amblyopia Treatment, sharing the latest clinical trial results with #RevitalVision. RevitalVision offers an effective solution to improve vision in amblyopia beyond the critical age, when occlusion therapy is no longer effective. It is the only FDA cleared and CE -Marked product for older children and adults with amblyopia. The presentation will take place on: June 13, 2024 , 11:35-12:35 We look forward to seeing you at ESA-ISA 2024 and hope you will join us for this enlightening session. #ESAISA2024 #Strabismology #Ophthalmology #AdultAmblyopia #VisionCare #EyeHealth #InnovativeTreatment #MedicalResearch #amblyopia
-
-
In this article featured on BW HEALTHCARE WORLD ; "Using Brain Science to Improve Low Vision in 2024," Dr. Monica Samant discusses innovative approaches that leverage neuroplasticity to improve visual capabilities, providing new hope for low vision patients. This approach represents a shift from traditional optical corrections, focusing instead on the brain's role in visual perception. A standout technology in this field is RevitalVision, which uses clinically proven visual training programs to stimulate the visual cortex, resulting in vision improvementn for conditions such as amblyopia, eye diseases, and other visual impairments. A special thanks to the author Dr. Monica Samant for shedding light on this groundbreaking work. This not only broadens our understanding of vision science but also brings practical benefits to those affected by low vision. Read the full article: https://lnkd.in/dYEi8Vqc Here are some relevant hashtags to use on LinkedIn for this post: #BrainScience #LowVision #VisionHealth #Neuroplasticity #VisualImpairment #VisionImprovement #HealthcareInnovation #Neuroscience #RevitalVision #EyeCare #MedicalTechnology #HealthTech #VisionTherapy #PatientCare
Using Brain Science To Improve Low Vision In 2024
bwhealthcareworld.com
-
Eye care professionals? Hear from top industry leaders about improving vision in Amblyopia- beyond the critical age Join us on Thursday for a Doctors' webinar on Improving Vision in Amblyopia! Learn how leading experts Dr. Geetha Srinivasan and Dr. Digvijay Singh used RevitalVision software to improve patients' vision and quality of life. Register here: https://lnkd.in/d-B5Az5b #amblyopia #eyecareprofessionals #india #opthalmology #lowvision
-
-
👁️Exclusive webinar for Eye Care Professionals!👁️ 🔍Learn how leading experts Dr. Geetha Srinivasan and Dr. Digvijay Singh used RevitalVision software to improve patients' vision and quality of life. 🗓️Save the date: 16th May, 5-6 pm (India Standard Time) Secure your spot today and gain valuable Insights! Register here: https://lnkd.in/d-B5Az5b #amblyopia #eyecareprofessionals #india #opthalmology #eyecare
-
-
Improving Vision in Congenital Nystagmus - Pivotal RCT Results - presented at AAPOS 20024 We are happy to share the groundbreaking findings from a prospective randomized controlled trial evaluating RevitalVision's efficacy in improving vision in Congenital Nystagmus patients. The study demonstrated statistically significant improvement in distance and near BCVA, as well as substantial improvement in binocular and stereo vision, giving hope to nystagmus patients who are lacking alternative solutions. Watch the recorded presentation of Dr. Idan Hecht from last week's AAPOS annual meeting. RevitalVision offers an effective tool to improve vision in nystagmus and amblyopic patients age 9 or older, with a prescribed, home-based cortical-stimulation software program. For more information go to https://lnkd.in/dsM6aUxe or contact us at [email protected] #nystagmus #aapos #lowvision #opthalmology #pediatricopthalmology